Speaker Profile
PhD, Co-Founder & CEO, Huma.AI
Biography
Dr. Feng spent over 20 years in precision medicine. Dr. Feng came from NovartisOncology Business Unit where she established international partnerships fortheir targeted cancer therapeutics programs. She joined Novartis through itsacquisition of Genoptix. Dr. Feng built the BioPharma division at Genoptix,where she grew the business from zero to $45M in five years by forging allianceswith pharmaceutical companies and providing companion diagnosticsdevelopment for targeted cancer therapies. The division was instrumental inGenoptix acquisition by Novartis for $500M.
AI and Data Sciences Showcase:
Huma.AI
Huma.AI is a pioneer in generative AI, providing its own “ChatGPT” for Life Sciences
through direct collaboration with OpenAI. Huma.AI allows Life Science teams to
comprehend the competitive landscape from multiple perspectives quickly.
Session Abstract – PMWC 2024 Silicon Valley
The PMWC 2024 AI Company Showcase will provide a 15-minute time slot for selected AI companies to present their latest technologies to an audience of leading investors, potential clients, and partners. We will hear from companies building technologies that expedite the pre-clinical and clinical drug discovery and development process, accelerate patient diagnosis and treatment, or develop scalable systems framework to make AI and deep/machine learning a reality.
